Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.
- 1 June 1994
- Vol. 71 (6), 504-507
- https://doi.org/10.1136/hrt.71.6.504
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a priceCardiovascular Research, 1993
- Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.Heart, 1993
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Shear stress increases inositol trisphosphate levels in human endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeThe American Journal of Cardiology, 1988
- Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985